Table 2.
Total |
Referred |
Prescribed |
|||||
---|---|---|---|---|---|---|---|
N | n | % | n | % | |||
Overall | 41,500 | 6,318 | 15.2 | 26,065 | 62.8 | ||
Male | 17,183 | 2,467 | 14.4 | 10,405 | 60.6 | ||
Age | |||||||
15–24 | 5,925 | 813 | 13.7 | 2,397 | 40.5 | ||
25–34 | 3,898 | 586 | 15.0 | 2,485 | 63.8 | ||
35–44 | 3,702 | 557 | 15.1 | 2,698 | 72.9 | ||
45–54 | 2,374 | 337 | 14.2 | 1,818 | 76.6 | ||
55–64 | 1,284 | 174 | 13.6 | 1,007 | 78.4 | ||
IMD quintile | |||||||
1 | 2,182 | 383 | 17.6 | 1,318 | 60.4 | ||
2 | 2,743 | 439 | 16.0 | 1,647 | 60.0 | ||
3 | 3,185 | 488 | 15.3 | 1,969 | 61.8 | ||
4 | 4,146 | 548 | 13.2 | 2,530 | 61.0 | ||
5 | 4,927 | 609 | 12.4 | 2,941 | 59.7 | ||
Female | 24,317 | 3,851 | 15.8 | 15,660 | 64.4 | ||
Age | |||||||
15–24 | 10,368 | 1,557 | 15.0 | 4,364 | 42.1 | ||
25–34 | 4,348 | 780 | 17.9 | 3,293 | 75.7 | ||
35–44 | 4,957 | 841 | 17.0 | 4,069 | 82.1 | ||
45–54 | 3,255 | 497 | 15.3 | 2,754 | 84.6 | ||
55–64 | 1,389 | 176 | 12.7 | 1,180 | 85.0 | ||
IMD quintile | |||||||
1 | 3,444 | 632 | 18.4 | 2,207 | 64.1 | ||
2 | 4,255 | 776 | 18.2 | 2,771 | 65.1 | ||
3 | 4,610 | 752 | 16.3 | 2,939 | 63.8 | ||
4 | 5,718 | 824 | 14.4 | 3,698 | 64.7 | ||
5 | 6,290 | 867 | 13.8 | 4,045 | 64.3 |
Patients that did not complete one year of follow-up were excluded
IMD quintile 1 denotes least deprived and quintile 5 most deprived